Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of CL25216 on Vasomotor Symptoms in Women During Perimenopause: a Randomised, Double-blind, Placebo-controlled Study

NCT07112651 is registered in ClinicalTrials.gov with ApexCPG LLC as lead sponsor.

NCT NCT07112651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07112651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of CL25216 on Vasomotor Symptoms in Women During Perimenopause: a Randomised, Double-blind, Placebo-controlled Study
Lead sponsor
ApexCPG LLC
Phase
Not applicable
Overall status
Recruiting
Start date
November 24, 2025
Completion date
June 12, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vasomotor symptoms